218857 RESULTS

Pimavanserin Trial Raises Hope for Treating Dementia-Related Psychosis

CONFERENCE COVERAGE 2017-12-13 Conference Coverage Advancing dementia can bring with it psychosis, which greatly adds to the burden of life with Alzheimer’s disease for both the sufferer and his or her carers. No drugs are approved to treat dementia-related psychosis. Used off-label, ...

Verubecestat Negative Trial Data: What Does it Mean for BACE Inhibition?

CONFERENCE COVERAGE 2017-12-12 Conference Coverage The room was packed at the recent Clinical Trials on Alzheimer’s Disease conference, when Mike Egan of Merck & Co. presented much-anticipated data of EPOCH, the first efficacy trial of his company’s BACE inhibitor verubecestat. An ...

Current Filters

No filters selected

Filter By

  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From